Axial stent strut angle influences wall shear stress after stent implantation: analysis using 3D computational fluid dynamics models of stent foreshortening by LaDisa, John F et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BioMedical Engineering OnLine
Open Access Research
Axial stent strut angle influences wall shear stress after stent 
implantation: analysis using 3D computational fluid dynamics 
models of stent foreshortening
John F LaDisa Jr1,2,5, Lars E Olson5, Douglas A Hettrick2,5, 
David C Warltier2,3,4,5, Judy R Kersten2,4 and Paul S Pagel*2,5
Address: 1Department of Pediatrics (Division of Cardiology), Stanford University, Palo Alto, California, USA, 2Department of Anesthesiology, the 
Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin, USA, 3Department of Medicine 
(Division of Cardiovascular Diseases), the Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, 
Wisconsin, USA, 4Department of Pharmacology and Toxicology, the Medical College of Wisconsin and the Clement J. Zablocki Veterans Affairs 
Medical Center, Milwaukee, Wisconsin, USA and 5Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin, USA
Email: John F LaDisa - jladisa@stanford.edu; Lars E Olson - lars.olson@marquette.edu; Douglas A Hettrick - doug.hettrick@medtronic.com; 
David C Warltier - warltier@mcw.edu; Judy R Kersten - jkersten@mcw.edu; Paul S Pagel* - pspagel@mcw.edu
* Corresponding author    
CFDrestenosisneointimal hyperplasiaatherosclerosisstent geometry
Abstract
Introduction: The success of vascular stents in the restoration of blood flow is limited by
restenosis. Recent data generated from computational fluid dynamics (CFD) models suggest that
the vascular geometry created by an implanted stent causes local alterations in wall shear stress
(WSS) that are associated with neointimal hyperplasia (NH). Foreshortening is a potential limitation
of stent design that may affect stent performance and the rate of restenosis. The angle created
between axially aligned stent struts and the principal direction of blood flow varies with the degree
to which the stent foreshortens after implantation.
Methods:  In the current investigation, we tested the hypothesis that stent foreshortening
adversely influences the distribution of WSS and WSS gradients using time-dependent 3D CFD
simulations of normal arteries based on canine coronary artery measurements of diameter and
blood flow. WSS and WSS gradients were calculated using conventional techniques in ideal (16 mm)
and progressively foreshortened (14 and 12 mm) stented computational vessels.
Results: Stent foreshortening increased the intrastrut area of the luminal surface exposed to low
WSS and elevated spatial WSS gradients. Progressive degrees of stent foreshortening were also
associated with strut misalignment relative to the direction of blood flow as indicated by analysis
of near-wall velocity vectors.
Conclusion: The current results suggest that foreshortening may predispose the stented vessel
to a higher risk of neointimal hyperplasia.
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Introduction
Stents are commonly used to treat coronary and periph-
eral vascular stenoses, but restenosis after implantation
remains a persistent problem. The mechanisms responsi-
ble for restenosis have yet to be clearly elucidated[1,7,14].
Many stent designs are currently used in the clinical set-
ting, and each of these designs has unique geometric and
mechanical properties[5,13,36]. A correlation between
stent geometry and the severity of subsequent neointimal
hyperplasia has been described in animal models and
humans[14,35,37,44]. We recently demonstrated that the
number, width and thickness of stent struts and the
deployment diameter and scaffolding created by an
implanted stent substantially affects the area of the
stented zone subjected to low wall shear stress (WSS)
using time-dependent 3D computational fluid dynamics
modeling[23,24]. We have also recently shown that these
areas of low WSS predict subsequent development of
neointimal hyperplasia in vivo[25].
Foreshortening (the difference between the desired and
actual stent length after deployment) is a potential limita-
tion of stent design that may affect stent performance and
the rate of restenosis. The deployment of all types of stents
is associated with deformation of struts about specific ver-
tices within each stent mesh. Foreshortening varies with
stent morphology because of differential deformation of
interconnected struts during deployment[2,40]. The angle
created between axially aligned stent struts and the princi-
pal direction of blood flow varies with the degree to which
the stent foreshortens after implantation. Thus, theoreti-
cally deleterious variations in WSS distribution may occur
in stent designs that demonstrate substantial degrees of
foreshortening. A previous study demonstrated that strut
angle influences cellular adhesion in vitro[12]. These data
suggest that changes in strut angle resulting from fore-
shortening contribute to an altered flow environment that
may be conducive to restenosis. In the current investiga-
Computational vessels implanted with 12, 14 or 16 mm stents consisting of 8 axial and circumferential repeating strut sections  that were deployed using a stent-to-artery diameter convention of 1.2 to 1 Figure 1
Computational vessels implanted with 12, 14 or 16 mm stents consisting of 8 axial and circumferential repeating strut sections 
that were deployed using a stent-to-artery diameter convention of 1.2 to 1. The diameter of the native vessel for all simula-
tions was 2.74 mm. The computational vessel implanted with the 16 mm stent was designated as the ideal stent length after 
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tion, we tested the hypothesis that foreshortening
adversely influences the distribution of WSS and WSS gra-
dients previously implicated in neointimal hyperplasia
using 3D computational fluid dynamics models.
Methods
Construction of stented computational vessels
A custom automated geometric construction and mesh
generation algorithm was used to construct idealized
computational arteries containing a slotted-tube stent
embedded within a normal unstented computational ves-
sel based on blood flow and diameter measurements
obtained from canine left anterior descending coronary
arteries[21]. The algorithm allows for the alteration of sev-
eral geometric parameters including the stent length and
diameter relative to that of the unstented portions of the
computational vessel. The thickness and width of all stent
struts were 0.096 and 0.197 mm, respectively. All compu-
tational vessels were composed of structured hexahedral
control volumes arranged in a three-domain butterfly
design that exploited symmetric stent and vessel proper-
ties to model one-fourth of the computational vessel.
Schematic illustration demonstrating measurement of the stent strut angle with respect to the primary direction of blood flow Figure 2
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Three time-dependent simulations were performed in
total. Computational vessels were created consisting of 8
axial and circumferential repeating strut sections that were
deployed using a stent-to-artery diameter ratio of 1.2 to 1
(Figure 1). The diameter of the unstented portions of the
computational vessels for all simulations was 2.74 mm.
The computational vessel within the stented region con-
formed to the geometry of the implanted stent as previ-
ously documented[3,7,11,31]. The length of the
computational stents were 12,14 or 16 mm where 16 mm
represents the ideal stent length after implantation and
the 14 and 12 mm stents represent progressive degrees of
foreshortening, respectively. The amount of foreshorten-
ing used in the current models (12 to 25%) is consistent
with stent foreshortening observed clinically[6,16]. The
stent strut angles with respect to the primary direction of
blood flow were 151°, 146° and 141°, for the 16, 14 and
12 mm stents, respectively. Maintaining the same number
of axial and circumferential repeating strut units through-
out each simulation facilitated the study of flow distur-
bances produced by this stent strut orientation angle with
respect to the primary direction of blood flow (Figure 2).
Computational model simulations
Simulations were performed using the commercially
available software package CFD-ACE (CRDRC; Hunts-
ville, AL, http://www.cfdrc.com). This software uses a
finite volume approach to solve the Navier-Stokes equa-
tions at the center of each hexahedral control volume.
Theoretical arteries were subjected to a blood flow veloc-
ity waveform obtained from a canine coronary artery
under normal resting conditions (Figure 3). A plug flow
velocity profile was imposed at the inlet of each vessel and
additional length was added to all arteries to allow for
fully developed flow[10,23]. An initial axial velocity of
0.105 m/s was imposed within the fluid domain at the
start of each simulation to avoid a "cold start" and
increase the likelihood of convergence. A zero pressure
boundary condition was imposed at the outlet of the com-
putational vessels. Simulations were conducted using a
backward Euler temporal differencing method to investi-
gate time-dependent changes in indices of WSS within the
stented portion of each vessel. Computational simula-
tions were conducted assuming a Newtonian, incom-
pressible fluid with a density of 1.06 g/cm3 and viscosity
of 3.7 cP. The Reynolds and Womersley numbers for all of
the simulations were approximately 105 and 2.91, respec-
tively.
Determination of wall shear stress indices
Wall shear stress was determined as the product of viscos-
ity and shear rate. A detailed discussion of this calculation
is presented elsewhere[24]. Briefly, the CFD-ACE flow
solver calculates shear rate during incompressible flow
using the second invariant of the strain rate tensor. Thus,
shear rate ( ) was determined as
 where u, v, and w are the x, y and z components of velocity
vector, u, respectively.
This definition accounts for pure shear as well as exten-
sional or elongational deformation in the flow domain.
Spatial wall shear stress gradients (WSSG) were calculated
during post-processing as discussed previously[15,23].
WSSG was used to quantify the influence of non-uniform
hemodynamic forces on adjacent intravascular cells. Pre-
vious studies have suggested that this spatial WSS inho-
mogeneity may correlate with the location of neointimal
hyperplasia in vivo[4,38,39] as was recently observed fol-
lowing chronic stent implantation into rabbit iliac arter-
ies[25]. Frictional forces that act predominantly in axial
and circumferential directions were most likely to cause
expansion of intracellular gaps and disrupt intracellular
junctions[28]. As a result, WSSG was calculated as
, where τw is the WSS in the
axial (z) and circumferential (θ) directions, respectively.
WSSG observed overlying stent struts were excluded from
the current analysis because these areas do not acutely
contain biologically active tissue immediately after acute
stent implantation.
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Blood flow velocity waveform measured in the proximal por- tion of a canine left anterior descending coronary artery and  used for the time-dependent simulations conducted in the  current investigation Figure 3
Blood flow velocity waveform measured in the proximal por-
tion of a canine left anterior descending coronary artery and 
used for the time-dependent simulations conducted in the 
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Quantification of simulation results
The threshold for comparing distributions of low WSS
between simulations was established at 5 dynes/cm2 for
comparison to previous work[23,24] and because vascu-
lar regions subjected to WSS below this value have been
shown to strongly correlate with sites of intimal thicken-
ing[17,18]. Regions of low WSS were also expressed as
percentages of the stent area within intrastrut regions in
the proximal, middle and distal portions of the stent in
order to determine perturbations produced by foreshort-
ening and stent strut orientation. Near-wall velocity vec-
tors were also visualized at spatial locations in the
proximal, middle and distal portions of the stent to
observe the behavior of blood flow in these regions.
WSSG have also been used previously to examine the
hypothesis that normally confluent cells react to nonuni-
form distributions of WSS in a way that promotes neointi-
mal hyperplasia[9,32,38]. The percentage of the vessel
wall subjected to WSSG values above 20 dynes/cm3 was
quantified and compared between simulations in the cur-
rent investigation. WSSG of this order of magnitude previ-
ously correlated with areas of neointimal hyperplasia in
the toe region of an end-to-side arterial anastomo-
sis[19,27,32].
Results
Mesh and time-step independence
Multiple simulations were performed to investigate spa-
tial mesh independence. The spatial mesh density was
four times greater in stented as compared to unstented
regions of the computational vessels resulting in approxi-
mately 250,000 nodes per quarter of each computational
artery. Results were considered to be spatially independ-
ent of the computational mesh when differences in the
distributions of WSS were less than 6% between succes-
sive mesh densities[20,30]. Simulations were performed
on a Dell Optiplex GX270 2.4 GHz workstation with 2
Gbyte of RAM that enabled convergence of simulations at
a rate of approximately 25 time-steps per day. Time-step
independence was examined by subjecting computational
vessels to the coronary artery blood flow velocity wave-
form illustrated in Figure 3 using time-step increments of
10.9, 8.0 or 5.4 ms. Three consecutive cardiac cycles were
allowed to reach simulation convergence, and distribu-
tions of WSS were compared at equivalent points during
each cardiac cycle and between waveform permutations.
The results demonstrated that a single cardiac cycle was
sufficient to allow for the evolution of initial conditions,
and simulation results became periodic shortly after the
first cardiac cycle. A time step increment of 8.0 ms was suf-
ficient to resolve temporal distributions of WSS within the
stented and unstented regions of each vessel.
Simulation results
Indices of WSS corresponding to the mean blood flow
velocity during the cardiac cycle are shown in Table 1.
Lower WSS was observed within the stented region of all
simulations, and stagnation zones occurred around stent
struts. The percentage of intrastrut area exposed to distri-
butions of WSS < 5 dynes/cm2 was greatest in the proxi-
mal portion of each stent independent of length and strut
orientation (Table 1). These intrastrut areas of low WSS
were least pronounced in the distal portion of the stents.
The percentage of intrastrut area exposed to WSS < 5
dynes/cm2 within a particular intrastrut region decreased
as the length of the stent increased. Conversely, the total
area of the stent exposed to WSS < 5 dynes/cm2 increased
as the stent length increased. However, when normalized
by the length of the stent, the percentage of the computa-
tional vessel subjected to WSS < 5 dynes/cm2 modestly
increased with the degree of foreshortening (0.78 as com-
pared to 0.71 mm2 for 16 and 12 mm stents, respectively).
The total area of the computational vessel subjected to
WSSG greater than 20 dynes/cm3 increased as the stent
length increased (67.4 versus 89.3 dynes/cm3 for 12 and
16 mm stents, respectively). In addition, the maximum
WSSG observed throughout the stented region decreased
as stent length increased (395, 293 and 248 dynes/cm3 for
the 12, 14 and 16 mm stents, respectively). When normal-
ized by the length of the stent, the portion of vessels sub-
jected to elevated WSSG was similar for each
computational vessel simulation (Table 1).
Value-weighted near-wall velocity vectors in the first prox-
imal, middle and last distal repeating stent unit resulting
from the unique strut orientation of each of the stents are
illustrated in Figure 4. Reductions in the size of the vectors
in the proximal as compared to the middle region resulted
from the increase in luminal diameter within the stented
region and account for the pronounced low WSS found in
the proximal portion of the computational stent in all
simulations. Adjacent blood layers appear to converge
before entering each repeating stent unit and diverge after
entering each axial diamond. This divergence accounted
for reductions in WSS adjacent to stent struts. Figure 4 also
demonstrates that the 12 mm stent foreshortening simu-
lation produced large deviations in value-weighted near-
wall velocity vectors adjacent to stent struts, in contrast to
the observations with computational stents deployed to
an ideal length of 16 mm.
Time-dependent alterations in the spatial distributions of
WSS throughout the cardiac cycle are illustrated in Figure
5. Stagnation regions observed adjacent to stent struts
developed immediately before blood flow deceleration at
the local and global maxima of the flow waveform (rows
2, 4 and 6). These stagnation regions were more pro-BioMedical Engineering OnLine 2005, 4:59 http://www.biomedical-engineering-online.com/content/4/1/59
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nounced in the 12 and 14 mm computational stents as
compared to the 16 mm simulation.
Discussion
Increasing evidence suggests that the geometry and physi-
cal properties of a deployed stent may influence the local
blood flow environment and alter distributions of WSS
after implantation, thereby rendering certain areas of the
vessel wall more susceptible to neointimal hyperplasia
and subsequent restenosis[11,29,31,43]. Our laboratory
has previously demonstrated that the number, width and
thickness of strut struts, the stent-to-artery deployment
diameter, and stent scaffolding influence the area of a ves-
sel exposed to low WSS and elevated spatial and temporal
WSSG using computational fluid dynamics models gener-
ated from measured in vivo data[20,23,24]. These results
suggested that stent geometry profoundly affects fluid
dynamics that correlate with the spatial and temporal
localization of neointimal hyperplasia as we recently
reported using a combined approach of chronic iliac
artery stent implantation in vivo, microfocal x-ray CT
imaging, computational fluid dynamics and vascular his-
tology[22,25,26].
The current results confirm and extend our previous
observations and further demonstrate the importance of
stent geometry on intravascular fluid dynamics. The cur-
rent findings with 3D computational fluid dynamics
modeling demonstrate that stent foreshortening increases
the area of the luminal surface exposed to low WSS and
elevated spatial WSSG. These data strongly suggest that
stent foreshortening may precipitate more pronounced
development of neointimal hyperplasia as compared to a
stent deployed to its ideal length. This hypothesis remains
to be tested in vivo, however. The angle created between
axially aligned stent struts and the principal direction of
blood flow varied with the deployed stent length. The cur-
rent results using computational foreshortened stents and
those deployed to their ideal length demonstrate that
struts of the foreshortened stents were progressively mis-
aligned with the direction of blood flow. This strut mis-
alignment within the flow domain also substantially
influenced the behavior of near-wall velocity vectors and
contributed to the observed increases in deleterious distri-
butions of WSS and WSSG in foreshortened as compared
to ideal computational stent architecture. Stent foreshort-
ening effectively increases the number of struts per unit
length of a vessel, and we have previously demonstrated
that such an increase in strut number is associated with
greater exposure of the luminal surface to low WSS and
elevated WSSG[23]. These previous and current observa-
tions are consistent with the intuitive notion that optimal
stent design should assure that the vast majority of struts
are aligned more parallel to blood flow in order to mini-
mize changes in laminar blood flow characteristics and
WSS distributions.
Although the normalized luminal area exposed to WSS <
5 dynes/cm2 was similar for each of the stents computa-
tionally modeled in the current investigation, it is impor-
tant to consider which of the parameters reported in Table
1 are most likely to influence the local cellular response
and be associated with neointimal hyperplasia. The table
clearly indicates that the angle of stent struts with respect
to the primary flow direction strongly influences the
intrastrut area of the vessel wall exposed to low WSS. Cells
in these pronounced areas of low WSS are more likely to
participate in the neointimal response. Normalizing the
total area of the vessel exposed to low WSS by the length
provides a less sensitive indication of the local impact on
cells within the stented region that are likely to contribute
to neointimal hyperplasia.
The current results require interpretation within the con-
straints of several potential limitations. Stents were
implanted in idealized computational representations of
healthy vessels and the results would likely differ if the
study was performed using computational models of vas-
cular disease. From a clinical perspective, stent diameter
typically increases with the degree of foreshortening. Such
Table 1: Stent properties and indices of wall shear stress
Stent Length (mm) 16 14 12
Luminal surface area covered by the stent (%) 24 22 19
Stent strut angle with respect to primary flow direction (°) 151 146 141
Proximal Intrastrut WSS < 5 dynes/cm2 (%) 48 52 55
Middle Intrastrut WSS < 5 dynes/cm2 (%) 18 46 50
Distal Intrastrut WSS < 5 dynes/cm2 (%) 12 21 48
Total area exposed to WSS < 5 dynes/cm2 (mm2) 117 111 96.8
Total area exposed to WSSG > 20 dynes/cm3 (mm2) 89.3 72.5 67.4
Normalized area exposed to WSS < 5 dynes/cm2 0.71 0.77 0.78
Normalized area exposed to WSSG > 20 dynes/cm3 0.54 0.50 0.54
WSSGmax (dynes/cm3) 248 293 395
Abbreviations: WSS = wall shear stress; WSSG = wall shear stress gradientBioMedical Engineering OnLine 2005, 4:59 http://www.biomedical-engineering-online.com/content/4/1/59
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Value-weighted near-wall velocity vectors in the proximal, middle and distal portions of the stent resulting from the unique  strut orientation angles corresponding to ideal (16 mm) and progressively foreshortened stents (14 and 12 mm) Figure 4
Value-weighted near-wall velocity vectors in the proximal, middle and distal portions of the stent resulting from the unique 
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Time-dependent alterations in spatial wall shear stress throughout the cardiac cycle in ideal stents (16 mm) and those with  progressive degrees of foreshortening (14 and 12 mm) Figure 5
Time-dependent alterations in spatial wall shear stress throughout the cardiac cycle in ideal stents (16 mm) and those with 
progressive degrees of foreshortening (14 and 12 mm).BioMedical Engineering OnLine 2005, 4:59 http://www.biomedical-engineering-online.com/content/4/1/59
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an increase in stent diameter would be expected to intrin-
sically produce a reduction in blood velocity, and hence
WSS, within the stented region. We conducted the current
investigation using a consistent diameter within the
stented region of each computational vessel in order to
isolate the influence of the incident strut angle on indices
of WSS independent of changes in vessel diameter. As a
result, the current results may actually underestimate the
relative amount of the computational vessels subjected to
low WSS and elevated spatial WSSG as a result of this
observed clinical increase in diameter often associated
with foreshortening. The current investigation was con-
ducted using a rigid-wall approximation and a simplified
outlet boundary condition. Previous studies have demon-
strated that implantation of 16 mm slotted-tube stents
into canine epicardial coronary arteries in vivo reduced
vessel compliance to zero within the stented region[21]
and that wall deformability does not greatly alter the
velocity field under normal conditions[34]. Nevertheless,
the results may differ from those observed clinically as a
result of arterial compliance proximal and distal to the
stented region and the ability of the distal vasculature to
vasodilate in response to local metabolic need, thus alter-
ing the upstream resistance through the stented segment.
The potential clinical applicability of the current results in
lieu of the widespread use of drug-eluting stents to treat
vascular stenoses also deserves comment. Recent reviews
suggested that drug-eluting stents may simply delay reste-
nosis, but do not facilitate healing of the intima that is
damaged by prior vascular disease or the stent implanta-
tion procedure. Thus, restenosis rates with drug-eluting
stent may ultimately be similar to bare metal
stents[8,33,41,42]. Moreover, this drug-eluting technol-
ogy may not be applicable to all patient populations and
locations within the arterial vasculature[8,33]. The current
results further support the hypothesis that local flow pat-
terns created by the stent should also be considered dur-
ing stent design so as to minimize indices of fluid
dynamics implicated in neointimal hyperplasia and to
avoid the use of exogenous cytotoxic or antiproliferative
agents.
Conclusion
In summary, the current results using 3D computational
fluid dynamics modeling indicate that foreshortening-
induced orientation of stent struts with respect to the
direction of blood flow is associated with increases in the
area of the vessel subjected to low WSS and high WSSG,
factors that have been previously correlated with subse-
quent neointimal hyperplasia in vivo. The change in inci-
dent strut angle with respect to the predominant flow
direction was modest between modeled foreshortened as
compared to ideal computational stents (141 to 151°),
but increasing the degree of foreshortening reduced the
axial alignment angle of stent struts and produced greater
intrastrut areas of low WSS and elevated WSSG. Stent
geometries that successfully restore distal perfusion but
produce the least disruption to the native flow environ-
ment may ultimately provide maximum chronic vessel
patency.
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